Premium
P3‐172: Apoe E4 Stratification of Alzheimer's Disease Patients Defines Two Distinct Sets of Plasma Metabolomics Markers Related to Lipid or Mitochondrial Metabolism Dysfunction
Author(s) -
Calero Miguel,
Calero Olga,
Rodríguez-Martín Andrés,
Veiga Sergio,
Portero Isabel,
Campos Yolanda,
López-Alonso Victoria,
García-Albert Luis
Publication year - 2016
Publication title -
alzheimer's and dementia
Language(s) - Spanish
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2016.06.1832
Subject(s) - apolipoprotein e , medicine , disease , declaration of helsinki , oncology , metabolomics , alzheimer's disease , informed consent , psychology , bioinformatics , clinical psychology , biology , pathology , alternative medicine
Sergio Veiga1, Andrés Rodríguez-Martín1, Olga Calero2 ,Isabel Portero3, Yolanda Campos4, Victoria López-Alonso4, Luís García-Albert4 , Miguel Calero5. (1) Biocross S.L., Valladolid (Spain); (2) CIBERNED and Chronic Disease Programme, Instituto de Salud Carlos III. Madrid, Spain; (3) IMMPULSO. Madrid, Spain (4) Chronic Disease Programme, Instituto de Salud Carlos III. Madrid, Spain; (5) Chronic Disease Programme, CIBERNED, and CIEN Foundation-Queen Sofia Foundation, Instituto de Salud Carlos III. Madrid, Spain